These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 20062924)

  • 41. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population.
    Dielis AW; Castoldi E; Spronk HM; van Oerle R; Hamulyák K; Ten Cate H; Rosing J
    J Thromb Haemost; 2008 Jan; 6(1):125-31. PubMed ID: 17988231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: hypercoagulability in patients with vascular access thrombosis.
    Jeong JC; Kim JE; Ryu JW; Joo KW; Kim HK
    Thromb Res; 2013 Nov; 132(5):604-9. PubMed ID: 24060191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia.
    Tchaikovski SN; Thomassen MC; Costa SD; Peeters LL; Rosing J
    Thromb Haemost; 2011 Nov; 106(5):914-21. PubMed ID: 21979881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants.
    Simioni P; Morboeuf O; Tognin G; Gavasso S; Tormene D; Woodhams B; Pagnan A
    Thromb Res; 2006; 117(5):523-8. PubMed ID: 15921724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Genetic risk factors of venous thromboembolism].
    Oner F; Kaya A; Doğan R; Numanoğlu N
    Tuberk Toraks; 2003; 51(1):60-9. PubMed ID: 15100907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
    Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
    Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.
    Navarro S; Medina P; Bonet E; Corral J; Martínez-Sales V; Martos L; Rivera M; Roselló-Lletí E; Alberca I; Roldán V; Mira Y; Ferrando F; Estellés A; Vicente V; Bertina RM; España F
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1435-40. PubMed ID: 23520161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic Determinants of Thrombin Generation and Their Relation to Venous Thrombosis: Results from the GAIT-2 Project.
    Martin-Fernandez L; Ziyatdinov A; Carrasco M; Millon JA; Martinez-Perez A; Vilalta N; Brunel H; Font M; Hamsten A; Souto JC; Soria JM
    PLoS One; 2016; 11(1):e0146922. PubMed ID: 26784699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased thrombin generation in inflammatory bowel diseases.
    Saibeni S; Saladino V; Chantarangkul V; Villa F; Bruno S; Vecchi M; de Franchis R; Sei C; Tripodi A
    Thromb Res; 2010 Mar; 125(3):278-82. PubMed ID: 19914688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of the F12 -4 C>T polymorphism on hemostatic tests.
    Corral J; Antón AI; Quiroga T; González-Conejero R; Pereira J; Roldán V; Vicente V; Mezzano D
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):632-9. PubMed ID: 20814302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
    Hoppe B; Tolou F; Dörner T; Kiesewetter H; Salama A
    Thromb Haemost; 2006 Oct; 96(4):465-70. PubMed ID: 17003923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation.
    Musial J; Brzezinska-Kolarz B; Zólcinski M; Lelakowski J; Szczeklik A
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):614-21. PubMed ID: 20460350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
    Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby IL; Kapraali M; Kechagias S; Lindahl TL; Almer S
    Thromb Res; 2014 Aug; 134(2):455-61. PubMed ID: 24913997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obesity and thrombin-generation profiles in women with venous thromboembolism.
    Sonnevi K; Tchaikovski SN; Holmström M; Antovic JP; Bremme K; Rosing J; Lärfars G
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):547-53. PubMed ID: 23470648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene.
    De Stefano V; Rossi E; Paciaroni K; D'Orazio A; Cina G; Marchitelli E; Pepe R; Leone G
    Haematologica; 2003 Jan; 88(1):61-6. PubMed ID: 12551828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
    Reitsma PH; van de Stolpe A
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
    Martini CH; Brandts A; de Bruijne EL; van Hylckama Vlieg A; Leebeek FW; Lisman T; Rosendaal FR
    Br J Haematol; 2006 Jul; 134(1):92-4. PubMed ID: 16803573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter.
    Amini Nekoo A; Iles D
    Thromb Res; 2008; 121(6):813-9. PubMed ID: 17931693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
    Ay C; Pabinger I
    Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.